OPPO and Nokia Sign 5G Patent Cross License Agreement, Both Parties Will End All Pending Litigation
水色草莓慷
发表于 2024-1-24 16:48:38
1322
0
0
On January 24th, OPPO announced the signing of a global patent cross licensing agreement with Nokia, which covers both parties' standard essential patents in 5G and other cellular communication technologies. Both parties will end all pending litigation in all jurisdictions after the agreement is signed. The specific terms of the agreement shall be kept confidential as agreed by both parties.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
You may like
- Before the US stock market, the three major futures indexes rose together, while Chinese concept stocks generally fell; TSMC's Q3 performance exceeded expectations, with a rise of over 6%; Uber intends to acquire travel giant Expedia; Q3 net sales f
- Nokia's global downsizing: Nearly 2000 employees have been laid off in Greater China
- ParTec files patent infringement lawsuit against Nvidia in Munich
- Nokia and Chunghwa Telecom reach extension agreement on 5G Advanced
- Zhihu and Tencent renew framework agreement
- JPMorgan Chase: Upgrade Nokia rating from 'neutral' to 'overweight' with an average target price of $4.86
- Xiaopeng Motors rises nearly 4%, company announces patents related to humanoid robots
- Beike terminates its agreement to acquire equity in Space Intelligence
- Kaken signs Stat6 global licensing agreement with Johnson&Johnson
- Jianxun Daily | Hengrui Pharmaceutical and IDEAYA signed an authorization agreement; Liu Zhongliang, the actual controller of Weikang Pharmaceutical, has been registered